Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector

SOUTHBOROUGH, Mass., April 03, 2024--Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector

Related Keywords

Rome ,Lazio ,Italy ,Patrick Flanagan ,John Balser ,Laura Stringham ,First Full Service ,Alliance For Regenerative Medicine ,Science First Approach ,Support Patient Access ,Science First Full Service ,Regenerative Medicine ,Gene Meeting ,Chief Executive Officer ,Chief Statistical ,Veristat Science First ,Veristat ,Gene Therapies ,Clinical Trials ,Consultancy ,Drug Development ,